About Entheon Biomedical
Entheon Biomedical is a company based in Vancouver (Canada) founded in 2006 was acquired by MPV Exploration in July 2020. Entheon Biomedical has raised $77.28 thousand across 3 funding rounds from investors including MPV Exploration. Entheon Biomedical has completed 1 acquisition, including Lobo Gene. Entheon Biomedical operates in a competitive market with competitors including Clairvoyant Therapeutics, Nirvana Life Science and Alvarius, among others.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Entheon Biomedical Corp.
-
Annual Revenue
Not available
-
Net Profit
-$220.96 K (USD)-5.97as on Nov 30, 2024
-
EBITDA
-$231.21 K (USD)-6.35as on Nov 30, 2024
-
Total Equity Funding
$77.28 K (USD)
in 3 rounds
-
Latest Funding Round
$346.02 K (USD), Post-IPO
Jan 03, 2025
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
MPV Exploration
(Jul 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Entheon Biomedical
Entheon Biomedical is a publicly listed company on the CSE with ticker symbol ENBI in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Entheon Biomedical
Unlock access to complete
Unlock access to complete
Funding Insights of Entheon Biomedical
Entheon Biomedical has successfully raised a total of $77.28K across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $346.02 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Entheon Biomedical
Entheon Biomedical has secured backing from 1 investor. Prominent investors backing the company include MPV Exploration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mineral exploration is focused on base metals projects.
|
Locked | Locked | Locked |
Investor details for Entheon Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Entheon Biomedical
Entheon Biomedical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lobo Gene.
Investment portfolio details for Entheon Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA testing for personalized cannabis responses is provided.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Entheon Biomedical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Entheon Biomedical
Detailed financials for Entheon Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Entheon Biomedical Comparisons
Peer comparison for Entheon Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Entheon Biomedical
Entheon Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clairvoyant Therapeutics, Nirvana Life Science and Alvarius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Psychedelic therapy drugs for addiction treatment are manufactured.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of opioid addiction
|
|
| Locked | Locked | Locked |
Develops bio-pharmaceutical treatments for addiction via psychedelics and therapy.
|
Detailed competitors of Entheon Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Entheon Biomedical
Complete news archive for Entheon Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Entheon Biomedical
Entheon Biomedical was founded in 2006 and raised its 1st funding round 14 years after it was founded.
Entheon Biomedical is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Entheon Biomedical is a funded company, having raised a total of $77.28K across 3 funding rounds to date.
Entheon Biomedical was founded in 2006 and is based in Vancouver, Canada. Psychedelic medicines targeting addiction and substance abuse disorders are developed within the biotechnology sector. Serotonin receptor modulating molecules have been created, alongside patented formulations based on psilocybin and DMT. These efforts focus on therapeutic applications for treating various addiction-related conditions through innovative molecular approaches.
Entheon Biomedical's top competitors include Clairvoyant Therapeutics, Nirvana Life Science and Alvarius.
Yes, Entheon Biomedical is publicly traded on CSE under the ticker symbol ENBI.
Entheon Biomedical has made 1 acquisition, including Lobo Gene.
Entheon Biomedical has 1 investor. Key investors include MPV Exploration.
The ticker symbol of Entheon Biomedical is ENBI on CSE.